![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2022/10/03/2526635/0/en/Eagle-Pharmaceuticals-and-Enalare-Therapeutics-Announce-FDA-Orphan-Drug-Designation-for-ENA-001-for-the-Treatment-of-Apnea-of-Prematurity-a-New-Chemical-Entity-Being-Developed-as-a.html
https://endpts.com/new-jersey-biotech-nets-50m-barda-contract-for-respiratory-candidate/
https://www.globenewswire.com/news-release/2022/08/09/2494636/0/en/Eagle-Pharmaceuticals-Takes-Equity-Stake-in-with-Option-to-Acquire-Enalare-Therapeutics-to-Advance-Global-Development-of-ENA-001-a-Novel-Agnostic-Respiratory-Stimulant.html
https://www.trialsitenews.com/a/nih-grants-2.8m-to-help-startup-advance-second-generation-breathing-stimulant-to-combat-opioidpolysubstance-respiratory-depression-8386f30e